NCT07538804 A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07535463 A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07535437 A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07526961 Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland Status COMPLETED Phase N/A
NCT07517640 Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT07513376 A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) Status RECRUITING Phase PHASE3
NCT07500285 Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II) Status NOT_YET_RECRUITING Phase PHASE2
NCT07489716 A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT07489703 SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT07489066 Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC Status NOT_YET_RECRUITING Phase PHASE2
NCT07485452 Boosting Osimertinib Blood Brain Barrier Penetration Status NOT_YET_RECRUITING Phase PHASE2
NCT07479277 Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC Status RECRUITING Phase NA
NCT07477808 Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07475637 Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase N/A
NCT07472647 SYS6090 Combination Therapy in Advanced Lung Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07467863 Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC Status RECRUITING Phase PHASE1/PHASE2